Statin use and outcomes of oncological treatment for castration-resistant prostate cancer

To compare the effect of statin use in relation to castration-resistant prostate cancer (CRPC) treatment, we assessed the risk of ADT-treated PCa-patients to initiate CRPC treatment by statin use and the outcomes of CRPC treatment by statin use. Our study cohort consisted of 1169 men who participate...

Descripción completa

Detalles Bibliográficos
Autores principales: Peltomaa, A. I., Talala, K., Taari, K., Tammela, T. L. J., Auvinen, A., Murtola, T. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620176/
https://www.ncbi.nlm.nih.gov/pubmed/37914793
http://dx.doi.org/10.1038/s41598-023-45958-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620176/
https://www.ncbi.nlm.nih.gov/pubmed/37914793
http://dx.doi.org/10.1038/s41598-023-45958-8

Ejemplares similares